Cigna Lays Off 2,000 Workers Worldwide in Healthcare Cost Squeeze

Why Is Cigna Cutting Jobs After Posting Record Earnings?

The Cigna Group is eliminating approximately 2,000 positions by the end of February 2026 -- a move that represents less than 3% of its global workforce but raises pointed questions about the state of the managed care industry. The layoffs arrived just days after the company reported fourth-quarter results that beat analyst expectations on both the top and bottom lines.

It is the kind of contradiction that has become disturbingly common across corporate America: strong profits, shrinking payrolls. Cigna is not cutting because it is failing. It is cutting because rising medical costs, regulatory pressure, and a demanding investor class are pushing the company to squeeze every available margin -- even in a quarter it technically won.

What Do We Know About the Layoffs?

A Cigna Group spokesperson confirmed the workforce reduction in a statement to Healthcare Dive, saying the company has "made the difficult decision to reduce roles in our workforce" as it drives "greater efficiency across the business." The cuts will be completed by the end of February 2026.

The company did not specify which departments, business units, or geographic regions would be most affected. Cigna had approximately 73,500 employees at the end of 2024, with about 90% based in the United States.

Affected workers will receive transition packages that include severance and support services, though Cigna did not disclose the specific terms. The company characterized the decision as one "made with deliberate care and focus."

This is not Cigna's first round of reductions. In 2025, the company laid off 143 Evernorth Care Group employees in Arizona following HonorHealth's acquisition of Evernorth clinic facilities, along with 62 Evernorth employees in New Jersey. Those were smaller, transaction-driven cuts. The current round is broader and more strategic in nature.

How Can a Company Beat Earnings and Still Lay Off Thousands?

This is the question that employees and outside observers keep asking -- and the answer lies in the gap between what happened last quarter and what Cigna expects for the year ahead.

For Q4 2025, Cigna posted adjusted earnings of $8.08 per share, beating the Wall Street consensus of $7.88. Revenue came in at $72.4 billion, also above the $70.3 billion forecast. Full-year 2025 adjusted income from operations reached $8.0 billion, or $29.84 per share -- a healthy increase from $27.33 per share in 2024.

But then came the 2026 outlook. Cigna projected full-year adjusted earnings of at least $30.25 per share on roughly $280 billion in adjusted revenue. While that represents growth, the guidance fell below what analysts had been expecting, signaling that Cigna's management sees tougher conditions ahead.

The medical care ratio (MCR) -- the percentage of premium revenue spent on actual medical claims -- is expected to land between 83.7% and 84.7% in 2026. That is a critical number. When the MCR rises, the insurer's profit margin on each premium dollar shrinks. Cigna is essentially telling investors that it expects to spend more on care, which means it needs to spend less everywhere else.

The layoffs are the "everywhere else."

What Is Driving Healthcare Cost Pressures?

The managed care industry is caught between two forces that are both accelerating: rising medical utilization and growing public scrutiny of insurance company profits.

On the cost side, healthcare utilization has been climbing steadily since the pandemic. Patients who delayed surgeries, screenings, and specialist visits in 2020 and 2021 have been catching up, driving higher claims volumes. At the same time, drug costs continue to escalate. GLP-1 medications like Ozempic and Mounjaro have become the most expensive drug category in the industry, with demand far outstripping initial projections.

Hospital systems and physician groups have also been consolidating and using their increased bargaining power to negotiate higher reimbursement rates from insurers. The result is a squeeze on margins that hits companies like Cigna, UnitedHealth, and Humana alike.

On the regulatory side, the FTC reached a settlement with Cigna's pharmacy benefit management arm, Express Scripts, over allegations of inflating insulin prices just days before the layoff announcement. While the company has not drawn a direct line between the settlement and the workforce reduction, the timing underscores the regulatory headwinds facing the entire PBM industry.

Congress has also been increasing scrutiny of PBM practices, with bipartisan proposals to increase transparency in drug pricing and limit spread pricing. These proposals, if enacted, could significantly impact Evernorth Health Services, Cigna's pharmacy and care delivery segment.

How Does Cigna's Move Compare to the Broader Insurance Industry?

Cigna is far from alone. The managed care sector has been shedding jobs and restructuring operations throughout 2025 and into 2026.

UnitedHealth Group, the industry's largest player, has been under enormous pressure following the tragic murder of its insurance division CEO in late 2024 and subsequent public backlash against claims denial practices. Humana has been dealing with rising costs in its Medicare Advantage business. Elevance Health (formerly Anthem) has also signaled caution on margins.

The Fierce Healthcare layoff tracker shows that healthcare layoffs in early 2026 extend well beyond insurers. Hospital systems, telehealth companies, and health tech startups have all been trimming workforces as the sector grapples with rising costs, tighter capital markets, and the aftermath of pandemic-era overexpansion.

For Cigna specifically, the company's dual identity as both a health insurer (Cigna Healthcare) and a pharmacy/care delivery company (Evernorth Health Services) creates unique pressure points. Evernorth's full-year 2026 earnings are expected to reach at least $6.9 billion, while Cigna Healthcare is projected at a minimum of $4.5 billion. Both segments are growing, but the growth rate is slowing, and the margin environment is tightening.

What Does Cigna's 2026 Outlook Actually Tell Us?

Reading between the lines of Cigna's guidance paints a picture of a company bracing for a difficult year while trying to maintain investor confidence.

Management expects $9 billion in operating cash flow for 2026, which is healthy by any standard. Shareholder dividends are expected to total approximately $1.6 billion, reflecting an increased quarterly dividend of $1.56 per share. The company is not in financial distress -- it is managing toward profitability targets that require continuous cost discipline.

The $280 billion revenue projection reflects continued growth in the pharmacy benefit management business, which processes prescription claims for millions of Americans. Evernorth remains the revenue engine, but its profitability depends on maintaining formulary leverage and controlling drug spend -- both of which face regulatory and competitive threats.

For shareholders, the message is: we can still grow, but we need to get leaner to do it. For employees, the message is bleaker: being part of a profitable company does not guarantee job security when the profit growth rate fails to meet Wall Street's expectations.

What Should Healthcare Workers Take Away From This?

The 2,000 jobs being cut at Cigna represent a small fraction of the hundreds of thousands of positions available across the healthcare industry. But they signal a broader shift in where and how healthcare companies are investing in people.

Front-line clinical roles -- nurses, physicians, therapists, pharmacy technicians -- remain in severe shortage across the country. The January 2026 jobs report showed healthcare adding 82,000 jobs in a single month, a pace that has been consistent for over two years.

The jobs disappearing are concentrated in corporate functions: administration, compliance, claims processing, IT support, and middle management. These are roles where automation, AI, and consolidation are reducing the number of humans needed to run large insurance operations. The trend is not unique to Cigna -- it is playing out across the entire managed care sector.

For workers in these corporate healthcare roles, the most effective hedge is developing expertise that crosses the boundary between clinical operations and business operations. Data analytics, population health management, value-based care design, and regulatory affairs all sit at the intersection of healthcare delivery and business strategy, making them harder to automate and more valuable in a consolidating industry.

Workers who are directly impacted by these layoffs should also know that the healthcare hiring market, broadly defined, remains one of the strongest in the U.S. economy. The skills developed at a large insurer -- claims management, provider network operations, benefits administration -- transfer readily to hospital systems, government health agencies, consulting firms, and the growing number of health tech companies still actively building teams.

For mid-career professionals in managed care, the disruption can actually create leverage. Companies like Centene, Molina Healthcare, and Oscar Health have been expanding their Medicare and Medicaid operations and need experienced talent. The pharmacy benefit management space -- despite its regulatory headaches -- continues to grow as healthcare costs drive demand for cost-containment expertise. Workers with experience navigating the complex intersection of clinical outcomes and financial management are in short supply, even as total headcounts at the largest insurers shrink.

The timing of the layoffs -- completed by the end of February -- means displaced workers will be entering the spring hiring cycle, which is historically one of the strongest periods for healthcare recruitment. Hospital systems and physician groups typically finalize budgets in Q1 and ramp hiring through the spring. Government health agencies, including state Medicaid offices and the Centers for Medicare & Medicaid Services, also tend to post openings in the first half of the year.

People Also Asked

Q: How many employees is Cigna laying off in 2026? A: The Cigna Group is cutting approximately 2,000 jobs globally, representing about 3% of its 73,500-person workforce. The layoffs are expected to be completed by the end of February 2026. The company has not disclosed which specific departments or regions are most affected but is providing severance and transition services to impacted employees.

Q: Why is Cigna cutting jobs if earnings beat expectations? A: While Cigna's Q4 2025 earnings of $8.08 per share beat the $7.88 estimate, the company's 2026 guidance of at least $30.25 per share came in below Wall Street expectations. Rising medical costs, increased healthcare utilization, and regulatory pressures on its pharmacy benefit management business are expected to squeeze margins, prompting the company to reduce operating costs preemptively.

Q: Is Cigna in financial trouble? A: No. Cigna reported $8.0 billion in adjusted operating income for full-year 2025 and expects $9 billion in operating cash flow for 2026. The company also increased its quarterly dividend to $1.56 per share. The layoffs are a cost-efficiency measure aimed at maintaining profit margins as medical costs rise, not a sign of financial distress.

Looking for your next opportunity? Metaintro surfaces verified roles you won't find on traditional job boards — sign up free and land your next role faster.